Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease

As the societal and economic burdens of Alzheimer's disease (AD) continue to mount, so does the need for therapies that slow the progression of the illness. Beta amyloid has long been recognized as the pathologic hallmark of AD, and the past decade has seen significant progress in the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobello, Kasia, Ryan, J. Michael, Liu, Enchi, Rippon, Gregory, Black, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265072/
https://www.ncbi.nlm.nih.gov/pubmed/22292124
http://dx.doi.org/10.1155/2012/628070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265072/
https://www.ncbi.nlm.nih.gov/pubmed/22292124
http://dx.doi.org/10.1155/2012/628070

Ejemplares similares